If you are in the healthcare or pharmaceutical industry, you may qualify to receive a complimentary Market Overview of our completed NetNog: #genesis® research.
NetNog: #genesis® NASH (including NAFL) is offered as a syndicated market research report and is available!
NetNog: #genesis® Alzheimer's (including MCI) is offered as a syndicated market research report and is available!
NetNog: #genesis® Cystic Fibrosis is offered as a syndicated market research report or a condensed version, which contains five patient/caregiver journeys (NetNog: #genesis® Cystic Fibrosis Patient and Caregiver Journeys)
NetNog: #genesis® helps align clinical trial design with your commercialization strategy so you have a higher ROI for your product. We contextualize consumer experiences by moving beyond the algorithm. NetNog: #genesis® delivers syndicated, ethnographic-quality research, which includes elements of NetNog: #buy® and NetNog: #talk®. NetNog: #genesis® research reports include:
The executive summary highlights key findings, multi-media representations of the patient, and common lexicon associated with the condition.
Market overview critically reviews epidemiology, pathophysiology, and a patient journey as defined by guidelines.
Digital dashboard offers a summation of the digital landscape by analyzing conversation volumes by social channels and top posters.
Using netnographic methodologies, NetNoggin® reports on patient and caregiver expressed journeys, outcomes, emotions, HCP interactions, resources, and more!
The implications section compares what should be happening (guidelines) in the market to patients/caregivers perspectives, as well as patient-expressed unmet needs.
After the purchase of NetNog: #genesis® research, NetNoggin® creates a customized presentation tailored to the needs and pain points of that specific company.
NetNog: #track™ Alzheimer’s Disease (including MCI) is the first NetNog: #track™ report. This is a syndicated, quarterly report that tracks brands and monitors how the market is being influenced by caregivers, HCPs, advocates, and organizations.
NetNog: #track™ Multiple Myeloma is coming soon.
NetNog: #track™ offers pharmaceutical companies an unprecedented advantage when developing marketing strategies for new/established products by understanding how brands influence the market online and where a product may/does fit. NetNog: #track™ delivers syndicated, quarterly reports, which includes elements of NetNog: #brand® and NetNog: #lead®, and NetNog: #monitor™. NetNog: #track™ research reports include:
Digital dashboard offers a review of the digital landscape by analyzing conversation volumes, reasons for volume spikes, and top posters.
Branded treatments reviews which brands are influencing conversations, the psychographics around the top brands, and top themes.
Influencers identifies who is influencing the market, how they influence the market, and the connections they have to other influencers.